Mortality and Quality of Life with Chronic Kidney Disease: A Five-Year Cohort Study with a Sample Initially Receiving Peritoneal Dialysis.

UNLABELLED

The quality of life, morbidity and mortality of people receiving renal replacement therapy is affected both by the renal disease itself and its treatment. The therapy that best improves renal function and quality of life is transplantation.

OBJECTIVES

To study the quality of life, morbidity and mortality of people receiving renal replacement therapy over a five-year period.

DESIGN

A longitudinal multicentre study of a cohort of people with chronic kidney disease.

METHODS

Patients from the Girona health area receiving peritoneal dialysis were studied, gathering data on sociodemographic and clinical variables through an ad hoc questionnaire, quality of life using the SF-36 questionnaire, and social support with the MOS scale.

RESULTS

Mortality was 47.2%. Physical functioning was the variable that worsened most in comparison with the first measurement ( = 0.035). Those receiving peritoneal dialysis ( = 0.068) and transplant recipients ( = 0.083) had a better general health perception. The social functioning of transplant recipients improved ( = 0.008).

CONCLUSIONS

People with chronic kidney disease had a high level of mortality. The dimension of physical functioning worsens over the years. Haemodialysis is the therapy that most negatively effects general health perception. Kidney transplantation has a positive effect on the dimensions of energy/vitality, social functioning and general health perception.